The patents in contention are 5,843,780, which covers primate embryonic stem cells and was issued in 1998; 6,200,806, which covers human and primate embryonic stem cells and was issued in 2001; and 7,029,913, which covers cultures of human or primate embryonic stem cells and was issued in 2006.
The bone of contention is a patent filed by Gibson back in 1999 for a head-mounted display that simulates the feeling of playing an instrument in a rock concert.
A trial on Mylan's contention that the patents are invalid could go to trial later this year.
A second phase of the trial will be held to consider Affymetrix's contention that Oxford's patent is invalid.
So the trial was focused on DuPont's contention that the Roundup Ready patent was invalid because Monsanto had deceived the United States Patent and Trademark Office by withholding information that might have prevented issuance of the patent.
It is estimated that for patent suits with less than $1 million under contention, median discovery costs and legal fees are $790,000; for suits between $1 million and $25 million these costs are $3 million; and for suits with more than $25 million at stake they rise to $6.5 million .9These figures do not include damages, which may be treble in cases where willful infringement is found.
Whether companies should even be able to patent software has been a bone of contention within the legal and technology industries for years.
One of TKT's major contentions is that Amgen's patent claims are overly broad and should not extend to human cells.
Schering's suit disputes Impax's contention in its application that two Schering patents for Claritin are invalid or unenforceable, or would not be infringed by its generic drug.
The issue has become a major point of contention as the World Trade Organization prepares to discuss new patent rules at its meeting in Qatar next week.
The CGPA's contention is that the brand-name companies continually listed new patents on a product, each of which can trigger a new NOA and an additional stay on the appearance of a generic.
